MEMPHIS, Tenn. - TelAve -- Cernum Biosciences today released a brief internal sales snapshot showing which peptides are drawing the strongest consumer interest across its catalog of all peptides.

The analysis found that Retatrutide is the most popular peptide, representing approximately 34% of demand. GHK-CU ranks second at approximately 24%. Together, those two products account for more than half of overall peptide demand.

A second tier of popularity includes CJC 1295 no DAC & Ipamorelin Blend at about 10% and BPC-157 at roughly 8%. At the other end of the ranking, the least popular peptides were Kisspeptin-10 and CJC-1295 (No DAC), each accounting for approximately 0.2% of demand, with IGF-1 LR3 also representing less than 1%.

More on TelAve News

• The New World of Freight Brokering with AI
• Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
• World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
• Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
• Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties

The company said the data reflects clear customer preference for a small number of leading peptides while also showing continued interest across a broader specialty category. More information is available on the company's article about consumer trends.

About Cernum Biosciences

Cernum Biosciences is a purity-focused company dedicated to advancing access to high-quality peptides and supporting innovation in the life sciences sector.